Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Article

  • Article
    Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines
    Beverly E. Barton, Thomas F. Murphy, Ping Shu, Hosea F. Huang, Marcus Meyenhofen and Arnold Barton
    Mol Cancer Ther October 1 2004 3 (10) 1183-1191;

  • Article
    Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines
    Caroline Patry, Bruno Lemieux, Raymund J. Wellinger and Benoit Chabot
    Mol Cancer Ther October 1 2004 3 (10) 1193-1199;

  • Article
    A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells
    Christopher M. Incles, Christoph M. Schultes, Helena Kempski, Heike Koehler, Lloyd R. Kelland and Stephen Neidle
    Mol Cancer Ther October 1 2004 3 (10) 1201-1206;

  • Article
    Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel
    Virginie Durbecq, Marianne Paesmans, Fatima Cardoso, Christine Desmedt, Angelo Di Leo, Stephen Chan, Kay Friedrichs, Tamas Pinter, Simon Van Belle, Elizabeth Murray, István Bodrogi, Euan Walpole, Bernard Lesperance, Stefan Korec, John Crown, Peter Simmonds, Thimothy J. Perren, Jean-Yves Leroy, Ghizlane Rouas, Christos Sotiriou, Martine Piccart and Denis Larsimont
    Mol Cancer Ther October 1 2004 3 (10) 1207-1214;

  • Article
    Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase
    Vincent A. Barvaux, Paul Lorigan, Malcolm Ranson, Amanda M. Gillum, R. Stanley McElhinney, T. Brian H. McMurry and Geoffrey P. Margison
    Mol Cancer Ther October 1 2004 3 (10) 1215-1220;

  • Article
    Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide
    Xiuxian Jiang, Baoguang Zhao, Robert Britton, Lynette Y. Lim, Dan Leong, Jasbinder S. Sanghera, Bin-Bing S. Zhou, Edward Piers, Raymond J. Andersen and Michel Roberge
    Mol Cancer Ther October 1 2004 3 (10) 1221-1227;

  • Article
    G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium
    Robin M. Scaife
    Mol Cancer Ther October 1 2004 3 (10) 1229-1237;

  • Article
    The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice
    Nhu-An Pham, James W. Jacobberger, Aaron D. Schimmer, Pinjiang Cao, Marcella Gronda and David W. Hedley
    Mol Cancer Ther October 1 2004 3 (10) 1239-1248;

  • Article
    Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias
    Marina Konopleva, Elena Elstner, Teresa J. McQueen, Twee Tsao, Andrey Sudarikov, Wei Hu, Wendy D. Schober, Rui-Yu Wang, David Chism, Steven M. Kornblau, Anas Younes, Steven J. Collins, H. Phillip Koeffler and Michael Andreeff
    Mol Cancer Ther October 1 2004 3 (10) 1249-1262;

  • Article
    Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor
    Qun Xu, Michelle Farah, Jack M. Webster and Richard J.H. Wojcikiewicz
    Mol Cancer Ther October 1 2004 3 (10) 1263-1269;

  • Article
    Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model
    Gilda G. Hillman, Yu Wang, Omer Kucuk, Mingxin Che, Daniel R. Doerge, Mark Yudelev, Michael C. Joiner, Brian Marples, Jeffrey D. Forman and Fazlul H. Sarkar
    Mol Cancer Ther October 1 2004 3 (10) 1271-1279;

  • Article
    BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors
    Hidesuke Fukazawa, Kohji Noguchi, Atsuko Masumi, Yuko Murakami and Yoshimasa Uehara
    Mol Cancer Ther October 1 2004 3 (10) 1281-1288;

  • Article
    Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists
    Jesus V. Soriano, Ningfei Liu, Yang Gao, Zhu-Jun Yao, Toshio Ishibashi, Charles Underhill, Terrence R. Burke Jr. and Donald P. Bottaro
    Mol Cancer Ther October 1 2004 3 (10) 1289-1299;

  • Article
    Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway
    Eddy Pasquier, Manon Carré, Bertrand Pourroy, Laurence Camoin, Ouafa Rebaï, Claudette Briand and Diane Braguer
    Mol Cancer Ther October 1 2004 3 (10) 1301-1310;

  • Article
    Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome
    Qing Chen, Sheng Tong, Mark W. Dewhirst and Fan Yuan
    Mol Cancer Ther October 1 2004 3 (10) 1311-1317;

  • Article
    Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in α-tubulin
    Frank Loganzo, Malathi Hari, Tami Annable, Xingzhi Tan, Daniel B. Morilla, Sylvia Musto, Arie Zask, Joshua Kaplan, Albert A. Minnick Jr., Michael K. May, Semiramis Ayral-Kaloustian, Marianne S. Poruchynsky, Tito Fojo and Lee M. Greenberger
    Mol Cancer Ther October 1 2004 3 (10) 1319-1327;

  • Article
    Novel peptide ligands for integrin α4β1 overexpressed in cancer cells
    Masahito Mikawa, Henry Wang, Linlang Guo, Ruiwu Liu, Jan Marik, Yoshikazu Takada, Kit Lam and Derick Lau
    Mol Cancer Ther October 1 2004 3 (10) 1329-1334;

Minireview

  • Minireview
    Targeting ErbB receptor signaling: A pan-ErbB approach to cancer
    Carolyn D. Britten
    Mol Cancer Ther October 1 2004 3 (10) 1335-1342;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 3 (10)
October 2004
Volume 3, Issue 10
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in α-tubulin

Jump to

  • Article
  • Minireview
Advertisement
  • Most Cited
  • Most Read
Loading
  • Anti-KIT DNA Aptamer Labeling in GIST
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Tipifarnib as a Precision Therapy for HRAS-Mutant HNSCC
  • Targeted Delivery of MMAE Using Bicycle Molecules
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement